Recent News

By Category: Research

Next Steps in U.S.-Iran Diplomacy: Vaccines

(PacificStandard) September’s historic dialogue between President Obama and Iran’s President Rouhani together with calls to seek constructive engagement opens the door to a little known but powerful foreign policy instrument, which could simultaneously create new life-saving vaccines. The cornerstone of vaccine diplomacy is two or more countries putting aside their ideological differences to engage in  Read More »

Closer to vaccine against C. difficile

(ScienceDaily) A group of leading scientists from across Europe have launched a three-year project aimed at developing an oral vaccine against Clostridium difficile, an infection that kills around 4,000 people a year (almost four-times more than MRSA) and for which there is currently no effective treatments.

UT Southwestern To Collaborate On Soligenix’s RiVax Ricin Vaccine For Biodefense

(BioNewsTexas) Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing biodefense medical countermeasures (MCMs), announced that they have submitted a full contract proposal to the National Institute of Allergy and Infectious Diseases (NIAID), Division of Microbiology and Infectious Diseases, for the advanced development of RiVax™, a vaccine MCM candidate against ricin. A multi-year, multi-million  Read More »

FAZD Center’s Enhanced Passive Surveillance System

(GlobalBiodefense) The National Center for Foreign Animal and Zoonotic Disease Defense (FAZD) last month received $2 million in federal funds from the Department of Homeland Security’s Science and Technology Directorate to develop a disease-surveillance technology designed to protect U.S. animal agriculture from potentially catastrophic outbreaks of infectious pathogens. The project has the potential for a  Read More »

Request for Proposal – Joint Biological Tactical Detection System

(GlobalBiodefense) The U.S. Army Contracting Center, on behalf of the Joint Project Manager – Nuclear Biological Chemical Contamination Avoidance (JPM-NBCCA), has issued a pre-solicitation notice for the Joint Biological Tactical Detection System (JBTDS) Engineering & Manufacturing Development phase. The effort includes options for Low Rate Initial Production and Full Rate Production.